Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    7091520 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Withdrawn Efficacy of Bevacizumab in Preventing Acute Respiratory Distress Syndrome (ARDS)
Conditions: Severe Sepsis;   Acute Respiratory Distress Syndrome
Interventions: Drug: Bevacizumab;   Drug: Placebo IV Solution

Indicates status has not been verified in more than two years